Florida Research Network   Report issue

For profit Phase 2
Founded: Gainesville FL United States (2000)

Organization Overview

First Clinical Trial
2012
NCT01679990
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Florida research Network, LLC 6800NW 9th Blvd Suite1, Gainesville, Florida 32605

Active Ingredients

Drugs in Phase 2 Trials (1)

allogeneic plx-pad cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Intermittent Claudication (Phase 2)

Peripheral Arterial Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1